Literature DB >> 22783894

Intoxication delirium following use of synthetic cathinone derivatives.

Thomas M Penders, Richard E Gestring, Dmitry A Vilensky.   

Abstract

BACKGROUND: In published reports of hallucinatory delirium following use of "bath salts" analytic laboratory testing has demonstrated the synthetic cathinone derivative methylenedioxypyrovalerone (MDPV). MDPV can cause a false-positive screening immunoassay result for phencyclidine (PCP). Patients using MDPV are prone to development of the syndrome of excited delirium (ExD), a condition also described with PCP.
OBJECTIVE: This review summarize reports from several series of cases of delirium associated with MDPV emphasizing the features of both intoxication and excited delirium.
METHODS: Literature review and clinical description of a series of patients from Eastern North Carolina.
CONCLUSION: MDPV is likely the responsible agent in production of both toxic and excited delirium syndromes identified with the recreational use of "bath salts" in the United States over the past two years. SCIENTIFIC SIGNIFICANCE: Patients using MDPV are prone to the development of toxic delirum with some developing ExD. a condition associated with considerable risk for serious medical morbidity. Commonly used interventions directed at extreme agitation and paranoia may exacerbate the pathophysiology of ExD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22783894     DOI: 10.3109/00952990.2012.694535

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  18 in total

1.  Novel psychoactive drug use among younger adults involved in US nightlife scenes.

Authors:  Brian C Kelly; Brooke E Wells; Mark Pawson; Amy Leclair; Jeffrey T Parsons; Sarit A Golub
Journal:  Drug Alcohol Rev       Date:  2013-06-24

2.  Intoxications associated with agitation, tachycardia, hypertension, and Fever: differential diagnosis, evaluation, and management.

Authors:  Christopher J Keary; Shamim H Nejad; J J Rasimas; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-05-16

3.  Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.

Authors:  Kayla N Ellefsen; Sébastien Anizan; Marisol S Castaneto; Nathalie A Desrosiers; Thomas M Martin; Kevin L Klette; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-03-21       Impact factor: 3.345

Review 4.  Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature.

Authors:  Joji Suzuki; Michael A Dekker; Erin S Valenti; Fabiola A Arbelo Cruz; Ady M Correa; Justin L Poklis; Alphonse Poklis
Journal:  Psychosomatics       Date:  2014-11-06       Impact factor: 2.386

Review 5.  Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Authors:  Michael H Baumann; Mohammad O Bukhari; Kurt R Lehner; Sebastien Anizan; Kenner C Rice; Marta Concheiro; Marilyn A Huestis
Journal:  Curr Top Behav Neurosci       Date:  2017

6.  Electrical weapons and excited delirium: shocks, stress, and serum serotonin.

Authors:  Mark W Kroll; Stacey L Hail; Ryan M Kroll; Charles V Wetli; John C Criscione
Journal:  Forensic Sci Med Pathol       Date:  2018-08-11       Impact factor: 2.007

7.  The synthetic cathinone psychostimulant α-PPP antagonizes serotonin 5-HT2A receptors: In vitro and in vivo evidence.

Authors:  Yiming Chen; Bruce E Blough; Kevin S Murnane; Clinton E Canal
Journal:  Drug Test Anal       Date:  2019-04-22       Impact factor: 3.345

Review 8.  Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.

Authors:  Richard A Glennon
Journal:  Adv Pharmacol       Date:  2014

9.  Cytotoxic Activity of Pyrovalerone Derivatives, an Emerging Group of Psychostimulant Designer Cathinones.

Authors:  Jakub Wojcieszak; Dariusz Andrzejczak; Agata Woldan-Tambor; Jolanta B Zawilska
Journal:  Neurotox Res       Date:  2016-06-13       Impact factor: 3.911

10.  Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Julie A Marusich; Kateland R Antonazzo; Jenny L Wiley; Bruce E Blough; John S Partilla; Michael H Baumann
Journal:  Neuropharmacology       Date:  2014-03-02       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.